Statistics for Haemonetics (id:9160 HAE)

Valuation metrics

Market cap

4.43B

Enterprise value

5.50B

Trailing P/E (ttm)

36.59

Forward P/E

16.51

PEG ratio

16.51

Price/Sales (ttm)

3.25

Price/Book (mrq)

5.05

Enterprise Value/Revenue

4.04

Enterprise Value/EBITDA

17.49

Overview

Shares outstanding

50.22M

Float

49.73M

Shares short

5.16M

% Held by insiders

0.01%

% Held by institutions

1.14%

Average volume (10 days)

923.66K

Average volume (90 days)

Price summary

52-Week low

70.25

52-Week high

97.97

52-Week change

4.65%

Beta

0.32

50-Day moving average

77.55

200-Day moving average

81.78

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

December 03th, 2012

Financials

Fiscal year

Fiscal year ends

March 30th, 2024

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

9.10%

Operating margin

16.44%

Operational effectiveness

Return on assets

5.88%

Return on equity

13.97%

Income statement

Revenue (ttm)

26.77

Revenue per share (ttm)

26.77

Quarterly revenue growth (yoy)

0.36

Gross profit (ttm)

691.55M

EBITDA

274.90M

Net income to common (ttm)

123.81M

Diluted EPS (ttm)

2.41

Quarterly earnings growth (yoy)

35.80%

Balance sheet

Total cash (mrq)

300.03M

Total cash per share (mrq)

5.97

Total debt (mrq)

1.31B

Total Debt/Equity (mrq)

149.62

Current ratio (mrq)

348.90%

Book value per share (mrq)

17.44

Cash flow

Cash flow statement

84.94M

Levered free cash flow (LFCF)

85.98M